tyrphostin ag 1024 has been researched along with Disease Exacerbation in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, YH | 1 |
| Tang, HX | 1 |
| Liao, YD | 1 |
| Fu, SL | 1 |
| Xu, LQ | 1 |
| Chen, G | 1 |
| Zhang, C | 1 |
| Ju, S | 1 |
| Liu, ZG | 1 |
| You, LK | 1 |
| Yu, L | 1 |
| Zhou, S | 1 |
1 other study available for tyrphostin ag 1024 and Disease Exacerbation
| Article | Year |
|---|---|
Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer.
Topics: Adult; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Disease Models, Animal; Di | 2015 |